Viewing Study NCT06641128

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:11 AM
Ignite Modification Date: 2026-02-03 @ 9:21 AM
Study NCT ID: NCT06641128
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-10-17
First Post: 2024-10-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: The Possible Efficacy and Protective Effect of Empagliflozin in Rheumatoid Arthritis Patients Treated with Methotrexate
Sponsor: Tanta University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rheumatoid Arthritis (RA) View
None Methotrexate Induced Nephrotoxicity View
None Methotrexate Adverse Reaction View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rheumatoid Arthritis View
None Methotrexate side effect View
None empagliflozin role in RA View